Lori Leslie, MD Medical Oncologist, Regional Cancer Care Associates, discusses how physicians should be thinking about the use of BTK inhibitors in the treatment of chronic lymphocytic leukemia.
Use of BTK Inhibitors in CLL
Lori Leslie, MD Medical Oncologist, Regional Cancer Care Associates, discusses how physicians should be thinking about the use of BTK inhibitors in the treatment of chronic lymphocytic leukemia.